enVVeno Medical (NASDAQ:NVNO - Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, July 30th. Analysts expect enVVeno Medical to post earnings of ($0.28) per share for the quarter.
enVVeno Medical (NASDAQ:NVNO - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported ($0.22) earnings per share (EPS) for the quarter. On average, analysts expect enVVeno Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
enVVeno Medical Trading Down 1.2%
Shares of NASDAQ NVNO traded down $0.06 during mid-day trading on Friday, hitting $4.96. The company had a trading volume of 188,464 shares, compared to its average volume of 128,295. enVVeno Medical has a 1 year low of $2.03 and a 1 year high of $5.91. The company has a market capitalization of $87.00 million, a price-to-earnings ratio of -4.20 and a beta of 0.93. The stock's 50-day moving average price is $4.11 and its 200-day moving average price is $3.42.
enVVeno Medical Company Profile
(
Get Free Report)
enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
See Also
Before you consider enVVeno Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and enVVeno Medical wasn't on the list.
While enVVeno Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
